Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Inventory Average (2023 - 2025)

Iovance Biotherapeutics has reported Inventory Average over the past 3 years, most recently at $51.7 million for Q4 2025.

  • Quarterly results put Inventory Average at $51.7 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $51.7 million (changed N/A YoY), and the annual figure for FY2025 was $51.6 million, up 66.74%.
  • Inventory Average for Q4 2025 was $51.7 million at Iovance Biotherapeutics, up from $50.8 million in the prior quarter.
  • Over the last five years, Inventory Average for IOVA hit a ceiling of $58.5 million in Q1 2025 and a floor of $9.5 million in Q3 2023.
  • Median Inventory Average over the past 3 years was $50.8 million (2025), compared with a mean of $36.0 million.
  • Peak annual rise in Inventory Average hit 318.25% in 2025, while the deepest fall reached 318.25% in 2025.
  • Iovance Biotherapeutics' Inventory Average stood at $9.8 million in 2023, then surged by 43.04% to $14.0 million in 2024, then surged by 269.39% to $51.7 million in 2025.
  • The last three reported values for Inventory Average were $51.7 million (Q4 2025), $50.8 million (Q3 2025), and $57.7 million (Q2 2025) per Business Quant data.